Cancer Genetics Inc (NASDAQ:CGIX)

1.01
Delayed Data
As of 4:00pm ET
 +0.01 / +1.00%
Today’s Change
0.90
Today|||52-Week Range
4.78
-45.41%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Operating ActivitiesNet Income / Starting Line-16.6M-20.2M-15.8M-20.9M
 
 
 
 
 
Depreciation838.6K1.7M2.4M2.2M
 
 
 
 
 
Total Other Cash Flow4.6M4.0M1.2M10.6M
 
 
 
 
 
Funds From Operations-11.2M-14.5M-12.2M-8.1M
 
 
 
 
 
Funds From/For Other Operating Expenses1.2M-934.0K5.6M5.4M
 
 
 
 
 
Net Cash Flow - Operating Activities-12.3M-13.6M-17.9M-13.6M
 
 
 
 
 
 
InvestingIncrease In Investments-1.0M0.000.00-250.0K
 
 
 
Decrease In Investments0.006.0M0.0050.0K
 
 
 
Capital Expenditures-1.4M-1.0M-490.0K-1.3M
 
 
 
 
 
Fixed Asset Disposal312.0K-7.5M0.00--
 
 
 
Net Assets From Acquisitions -3.2M0.000.00-1.1M
 
 
 
Other Investing - Uses-6.0M0.000.000.00
 
 
Net Cash Flow Investing-11.4M-2.6M-609.0K-2.8M
 
 
 
 
 
 
FinancingShort Term Borrowings----------
Long Term Borrowings0.00-33.0K0.009.9M
 
 
 
Long Term Debt Reduction-452.2K-83.0K-1.5M-4.9M
 
 
 
 
 
Net Proceeds Stock Sale257.1K10.3M10.0M11.4M
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends0.000.000.000.00--
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing0.000.000.000.00--
Other Uses - Financing0.000.000.000.00--
Net Cash Flow - Financing-195.1K10.1M8.5M16.3M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash------16.0K
 
 
 
Net Change In Cash-23.9M-6.1M-10.0M23.0K